about
Madarosis from mitochondriopathyComplications of mitomycin C therapy in 100 eyes with ocular surface neoplasiaMalignant fibrous histiocytoma of the eyelid: differential diagnosis and management.Pooled genome wide association detects association upstream of FCRL3 with Graves' disease.Ophthalmic findings in Apert's syndrome after craniofacial surgery: twenty-nine years' experience.Ophthalmic findings in apert syndrome prior to craniofacial surgery.Madarosis.Pathogenesis of thyroid eye disease: review and update on molecular mechanisms.Conjunctival Lymphoma--An International Multicenter Retrospective Study.Association of Polymorphisms in MACRO Domain Containing 2 With Thyroid-Associated Orbitopathy.Risk Factors for Graves' Orbitopathy; the Australian Thyroid-Associated Orbitopathy Research (ATOR) Study.Massive retinal gliosis with episcleral extension.Differential Gene Expression Profiling of Orbital Adipose Tissue in Thyroid Orbitopathy.Ocular adnexal diffuse large B-cell lymphoma: a multicenter international study.Endoscopic sinus surgery for paranasal sinus mucocoele with orbital involvement.Differential effects of FGFR2 mutation in ophthalmic findings in Apert syndromeSerum selenium status in Graves’ disease with and without orbitopathy: a case-control studyCan the specificity of the FDT for glaucoma be improved by confirming abnormal results?Sebaceous gland carcinoma of the eyelid presenting as a conjunctival papillomaMedial transconjunctival intrinsic optic nerve biopsy: surgical technique and indicationsRecognising congenital glaucomaPrevalence of Oculo-auriculo-vertebral Spectrum in DermolipomaOrbital tuberculosis: perspectives from Victoria, AustraliaMedical treatment in thyroid eye disease in 2020
P50
Q28199911-02A76292-AC6A-429B-93E6-70E2D84128C9Q35761943-1E2E886A-B495-44CD-9A89-E433D5968DE0Q36075287-0E8865A6-7778-4DAC-9D44-7EC1D07DA4E2Q36198104-BF5020DF-B774-4254-8F09-9BB9DCE80044Q36386672-0D794E35-5A6C-44AD-A9AF-6D8D6B359F38Q36550593-59F7435A-CE75-44BA-A74D-9C403CFC38B9Q36668350-20B4A72C-DA74-4188-B2AA-B95A57C17E68Q38633022-082ADE9A-C2A3-4B13-BA72-444C70A9E3FCQ39986367-277C5413-7707-41CD-A197-4A316E1A53D7Q40700155-21B4B8B1-A6E3-431F-8AB4-6C8B8066998AQ40812821-DB749E50-EADD-41EC-AD21-09EF1BC26123Q48128600-75049581-A726-4538-ACA5-93C2E504B447Q50797233-2DD9E52F-AA4E-4C91-83AE-105AF3D4E76AQ51101772-A52FD25F-22B0-4D6D-80CF-E08328080277Q52553270-7B26062E-13F8-436E-A050-C3AED3272864Q56333986-44D596A1-600A-4E11-B719-1D8669E4EE5CQ59755196-67BBADDC-2FEF-46FB-B4B0-5259B68E139DQ74151229-61B450F7-05FB-43AA-8639-6FECD603B26AQ81609234-38F326FE-FA6F-4BD1-8FDD-92CD31FCD82BQ84219348-844FA7BC-52E5-4F85-9054-1F4C2E12F80EQ84737534-2470850F-A6B2-4B30-B1E3-6029AAA673A7Q86821101-1208C076-1C67-4923-B819-2549A4A4A460Q91021392-57436260-4FD1-47D6-8BF8-6EFD5BDAA4FFQ95648146-E909086D-8A4A-41FE-96B9-610CDA431B2F
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Jwu Jin Khong
@ast
Jwu Jin Khong
@en
Jwu Jin Khong
@es
Jwu Jin Khong
@nl
Jwu Jin Khong
@sl
type
label
Jwu Jin Khong
@ast
Jwu Jin Khong
@en
Jwu Jin Khong
@es
Jwu Jin Khong
@nl
Jwu Jin Khong
@sl
prefLabel
Jwu Jin Khong
@ast
Jwu Jin Khong
@en
Jwu Jin Khong
@es
Jwu Jin Khong
@nl
Jwu Jin Khong
@sl
P106
P31
P496
0000-0002-2660-4668